Product Description
Jardiance (empagliflozin) is a medication used to help manage type 2 diabetes and to reduce the risk of cardiovascular death in patients with heart disease. It belongs to a class of drugs known as SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors), which work by helping the kidneys remove excess sugar (glucose) from the bloodstream through urine.